NCT03841344View on ClinicalTrials.gov

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

NAUnknownINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

September 24, 2018

Study Completion Date

May 20, 2019

Conditions

Pulmonary Arterial Hypertension

Interventions

DEVICE

MRI

Evaluation of the utility of candidate endpoints in PAH trials

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Sheffield

OTHER

NCT03841344 - Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH | Biotech Hunter | Biotech Hunter